These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11484704)

  • 1. Paroxetine for the prevention of depression induced by interferon alfa.
    Kraus MR; Schäfer A; Scheurlen M
    N Engl J Med; 2001 Aug; 345(5):375-6. PubMed ID: 11484704
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
    Morasco BJ; Rifai MA; Loftis JM; Indest DW; Moles JK; Hauser P
    J Affect Disord; 2007 Nov; 103(1-3):83-90. PubMed ID: 17292481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine for the prevention of depression induced by high-dose interferon alfa.
    Musselman DL; Lawson DH; Gumnick JF; Manatunga AK; Penna S; Goodkin RS; Greiner K; Nemeroff CB; Miller AH
    N Engl J Med; 2001 Mar; 344(13):961-6. PubMed ID: 11274622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
    Kajitani K; Kanba S
    Psychosomatics; 2013; 54(5):506-7. PubMed ID: 23845321
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
    Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
    Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
    Ann Intern Med; 2012 Jul; 157(2):I-40. PubMed ID: 22801693
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing the neuropsychiatric complications of hepatitis C treatment.
    Sockalingam S; Shammi C; Stergiopoulos V
    Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Schaefer M; Berg T; Sarkar S; Neumann K
    Ann Intern Med; 2013 Jan; 158(2):140. PubMed ID: 23318324
    [No Abstract]   [Full Text] [Related]  

  • 10. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Landman GW
    Ann Intern Med; 2013 Jan; 158(2):139-40. PubMed ID: 23318323
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel treatment strategies for depression in patients with hepatitis C.
    Loftis JM; Turner EH
    Psychosomatics; 2010; 51(4):357-8. PubMed ID: 20587769
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression and hepatitis C.
    Sangwaiya A; Chan J; Ash S
    Br J Hosp Med (Lond); 2007 Dec; 68(12):682. PubMed ID: 18186414
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C.
    Fábregas B; Moura A; Ávila R; Carmo R; Teixeira AL
    Braz J Psychiatry; 2014; 36(2):183. PubMed ID: 24839091
    [No Abstract]   [Full Text] [Related]  

  • 14. Bupropion for treatment of interferon-induced depression.
    Malek-Ahmadi P; Ghandour E
    Ann Pharmacother; 2004; 38(7-8):1202-5. PubMed ID: 15150377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
    Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
    Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced depression treated with citalopram.
    Farah A
    J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
    McNutt MD; Liu S; Manatunga A; Royster EB; Raison CL; Woolwine BJ; Demetrashvili MF; Miller AH; Musselman DL
    Neuropsychopharmacology; 2012 May; 37(6):1444-54. PubMed ID: 22353759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
    J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders.
    Schaefer M; Winterer J; Sarkar R; Uebelhack R; Franke L; Heinz A; Friebe A
    Psychosomatics; 2008; 49(5):442-6. PubMed ID: 18794514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
    Raison CL; Woolwine BJ; Demetrashvili MF; Borisov AS; Weinreib R; Staab JP; Zajecka JM; Bruno CJ; Henderson MA; Reinus JF; Evans DL; Asnis GM; Miller AH
    Aliment Pharmacol Ther; 2007 May; 25(10):1163-74. PubMed ID: 17451562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.